Program Description
This program presents students and residents with an additional opportunity for a “hands on” fitting experience, while allowing them to assist the underserved. Established in 2007 as Adopt-A-Patient®, Give Brightly promotes a positive contact lens fitting experience for optometry students and residents.
Benefits of the Program
- Make an impact:
Serve your local community by fitting a patient who otherwise wouldn’t have access to contact lenses. - Gain experience fitting patients:
Receive an additional opportunity to fit a patient with contact lenses while in clinic.
How the Program Works
Optometry students and residents are encouraged to support a deserving patient from their community through this program, fit them with CooperVision® contact lenses, and provide appropriate follow-up care. Each student or resident, while in clinic, is allocated a specified supply of contact lenses from CooperVision for this purpose.
Who Is Eligible?
Each participating optometry school is responsible for determining patient eligibility. The underlying objective of this program is to improve the vision health of patients who would greatly benefit from contact lens wear but would otherwise be denied the opportunity because of their family’s income level.
While CooperVision leaves patient recruitment criteria up to the discretion of the clinic director at each school, program participants are generally third- and fourth-year optometry students and optometry residents.
Soft Contact Lenses
Myopia Management
Specialty Contact Lenses
*Indications: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
†Compared to a single vision 1 day lens over a 3 year period.
References:
1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567.
